Urology News and Research

Latest Urology News and Research

CrystalGenomics signs agreement with Dong-A ST for commercialization of Acelex (polmacoxib) in Korea

CrystalGenomics signs agreement with Dong-A ST for commercialization of Acelex (polmacoxib) in Korea

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Janssen signs license agreement with Alligator Bioscience for immuno-oncology antibody

Janssen signs license agreement with Alligator Bioscience for immuno-oncology antibody

Argos Therapeutics begins AGS-003 clinical trial in patients with metastatic renal cell carcinoma

Argos Therapeutics begins AGS-003 clinical trial in patients with metastatic renal cell carcinoma

Einstein and Montefiore researchers receive $1.2 million grant to advance spinal cord injury research

Einstein and Montefiore researchers receive $1.2 million grant to advance spinal cord injury research

Allergan receives FDA approval to market 28 additional styles of Natrelle 410 silicone-filled breast implants

Allergan receives FDA approval to market 28 additional styles of Natrelle 410 silicone-filled breast implants

WI Harper Group announces investment in Cold Genesys

WI Harper Group announces investment in Cold Genesys

Certain genes exposed to harsh environmental factors can increase diabetes risk

Certain genes exposed to harsh environmental factors can increase diabetes risk

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

High levels of specific proteins in urine can accurately detect early-stage pancreatic cancer

High levels of specific proteins in urine can accurately detect early-stage pancreatic cancer

John T. Spitznagel attains recognition in Strathmore's Who's Who for contributions in Healthcare Sales and Marketing

John T. Spitznagel attains recognition in Strathmore's Who's Who for contributions in Healthcare Sales and Marketing

New non-invasive spinal cord stimulation helps paralyzed men voluntarily move their legs

New non-invasive spinal cord stimulation helps paralyzed men voluntarily move their legs

Takeda completes post-marketing commitment and data submission for pioglitazone containing medicines

Takeda completes post-marketing commitment and data submission for pioglitazone containing medicines

Surgeons describe positive outcomes in kidney cancer patients treated with robotic IVC thrombectomy

Surgeons describe positive outcomes in kidney cancer patients treated with robotic IVC thrombectomy

New study reports creation of genetic porcine model of cancer

New study reports creation of genetic porcine model of cancer

Possible link discovered between common medications and falls in older men

Possible link discovered between common medications and falls in older men

American College of Surgeons calls for meaningful data sharing for improved patient care

American College of Surgeons calls for meaningful data sharing for improved patient care

Prostate cancer patients more likely to receive medical care matched to level of risk

Prostate cancer patients more likely to receive medical care matched to level of risk

York scientists identify how some micro-RNAs can make prostate cancers resistant to radiotherapy

York scientists identify how some micro-RNAs can make prostate cancers resistant to radiotherapy

Study examines link between use of diabetes drug pioglitazone and increased risk of bladder cancer

Study examines link between use of diabetes drug pioglitazone and increased risk of bladder cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.